CPHI vs DOCU · rev $4.1M vs P/E 15, rev $2.98B
China Pharma Holdings Inc (CPHI) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
DocuSign Inc (DOCU) is a software - application company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
CPHI currently screens at market cap $29.0M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the CPHI and DOCU stock pages for the full models.
Not investment advice.